Global Pulmonary Drugs Market Report 2019, Competitive Landscape, Trends and Opportunities
SKU ID : Maia-14377086 | Publishing Date : 25-Jun-2019 | No. of pages : 124
The report mainly studies the size, recent trends and development status of the Pulmonary Drugs market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Pulmonary Drugs market.
Major players in the global Pulmonary Drugs market include:
Novartis AG
AstraZeneca plc
Actelion Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Bayer AG
F. Hoffmann-La Roche Ltd.
Sunovion Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
Merck & Co., Inc.
GlaxoSmithKline plc
On the basis of types, the Pulmonary Drugs market is primarily split into:
Inhaled Corticosteroids (ICS)
Long-Acting Beta2-Agonists (LABA)
Antihistamine
Vasodilators
Short-Acting Beta2-Agonists (SABA)
Anticholinergics
Combination Drugs
MAbs
Enzymes
Antibiotics & Antileukotrienes
On the basis of applications, the market covers:
Asthma & COPD
Allergic Rhinitis
Pulmonary Arterial Hypertension
Cystic Fibrosis
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Pulmonary Drugs market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Pulmonary Drugs market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Pulmonary Drugs industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Pulmonary Drugs market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Pulmonary Drugs, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Pulmonary Drugs in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Pulmonary Drugs in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Pulmonary Drugs. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Pulmonary Drugs market, including the global production and revenue forecast, regional forecast. It also foresees the Pulmonary Drugs market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region